ABT
Abbott Laboratories
Position levels
Currenttoday
USD 105.70
Buy <=wait / entry
USD 96.00
Trim >=take some off
USD 112.00
Thesis breakA formal disclosure of a material cybersecurity incident affecting manufacturing...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 26% | 100 / 100 | 26.0 |
| Base case | 49% | 62 / 100 | 30.4 |
| Bear case | 25% | 10 / 100 | 2.5 |
| Weighted conviction | 59 / 100 - OPPORTUNISTIC BUY | ||
Top risks
- Completed acquisition of Exact Sciences on March 23, 2026, establishing leadership in oncology diagnostics market
- Q1 2026 results showing 7.8% reported sales growth and 6% adjusted diluted EPS growth to $1.15
- Updated full-year 2026 guidance for comparable sales growth of 6.5% to 7.5% and adjusted diluted EPS of $5.38 to $5.58 including acquisition dilution